As coronavirus hospitalizations rise, U.S. still doesn't have the test and trace tools in place, former FDA chief says

United States News News

United States Latest News,United States Headlines
  • 📰 CNBC
  • ⏱ Reading Time:
  • 17 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 72%

“I don’t think we have everything we need in place.” Dr. Scott Gottlieb says the U.S. has not yet put the necessary infrastructure in place to combat the coronavirus outbreak.

Covid-19 hospitalizations are on the rise in a number of states, Gottlieb told CNBC. Hospitalizations are a "lagging indicator" since it takes several weeks for someone to become sick enough to be admitted. But health officials say they are more telling than confirmed infections, which depend on the availability of testing. He said Tennessee, Arizona, Texas, Georgia, North Carolina, Minnesota, Wisconsin and Ohio have all seen hospitalizations rise.

The government should be making efforts to test "medically and socially disadvantaged people" who are more likely to contract Covid-19 but still don't have access to testing, Gottlieb said. He added that state and local officials should be rolling out "very aggressive tracking and tracing" strategies.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

CNBC /  🏆 12. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA struggles to remain independent amid race for virus cureFDA struggles to remain independent amid race for virus cureThe unprecedented effort by the White House to intercede at the FDA is raising alarms among health experts inside and outside the administration
Read more »

Antidepressant Zoloft and generic version in short supply, FDA saysAntidepressant Zoloft and generic version in short supply, FDA saysA spike in demand for anxiety and depression drugs has led to shortages of some forms of the commonly used antidepressant Zoloft and its generic, sertraline.
Read more »

Antidepressant Zoloft and generic version in short supply, FDA saysAntidepressant Zoloft and generic version in short supply, FDA saysThe shortage follows a sharp increase in reports of depression and anxiety in the U.S.
Read more »

Hype and science collide as FDA tries to rein in 'wild West' of COVID-19 blood testsHype and science collide as FDA tries to rein in 'wild West' of COVID-19 blood testsThe FDA is trying to rein in the chaos it created by allowing companies to flood the market with COVID-19 antibody tests of questionable accuracy.
Read more »

As coronavirus hospitalizations rise, U.S. still doesn't have the necessary tools in place, former FDA chief saysAs coronavirus hospitalizations rise, U.S. still doesn't have the necessary tools in place, former FDA chief saysThe government should be making efforts to test 'medically and socially disadvantaged people' who are more likely to contract Covid-19, but still don't have access to testing, Dr. Scott Gottlieb said.
Read more »



Render Time: 2025-03-26 17:35:10